Dermapharm Holding SE (FRA:DMP)
33.20
-0.30 (-0.90%)
At close: Aug 1, 2025, 10:00 PM CET
CTI BioPharma Market Cap
Dermapharm Holding SE has a market cap or net worth of €1.79 billion as of August 1, 2025. Its market cap has decreased by -7.13% in one year.
Market Cap
1.79B
Enterprise Value
2.67B
Revenue
1.20B
Ranking
n/a
PE Ratio
17.26
Stock Price
$33.20
Market Cap Chart
Since February 9, 2018, Dermapharm Holding SE's market cap has increased from 1.40B to 1.79B, an increase of 27.69%. That is a compound annual growth rate of 3.32%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 1, 2025 | 1.79B | -14.65% |
Dec 30, 2024 | 2.09B | -8.12% |
Dec 29, 2023 | 2.28B | 12.85% |
Dec 30, 2022 | 2.02B | -57.98% |
Dec 30, 2021 | 4.81B | 56.78% |
Dec 30, 2020 | 3.07B | 43.30% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Feb 9, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
SAP SE | 284.92B |
Siemens Aktiengesellschaft | 165.62B |
Deutsche Telekom AG | 151.49B |
Allianz SE | 127.59B |
Rheinmetall AG | 78.24B |
Siemens Energy AG | 77.38B |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 73.00B |
Deutsche Bank Aktiengesellschaft | 53.99B |